Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model

[1]  J. Shimony,et al.  Longitudinal Assessment of Neuroradiologic Features in Wolfram Syndrome , 2020, American Journal of Neuroradiology.

[2]  A. Terasmaa,et al.  GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome , 2019, Scientific Reports.

[3]  Si Jin,et al.  Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting , 2019, Neuroscience Bulletin.

[4]  B. Kennedy,et al.  The potential of small molecule brain-derived neurotrophic factor: mimetics to treat inherited retinal degeneration , 2019, Neural regeneration research.

[5]  A. Terasmaa,et al.  Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome , 2018, Scientific Reports.

[6]  Hui Fang,et al.  Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats. , 2018, Molecular medicine reports.

[7]  Chao-Ching Huang,et al.  Systemic 7,8-Dihydroxyflavone Treatment Protects Immature Retinas Against Hypoxic-Ischemic Injury via Müller Glia Regeneration and MAPK/ERK Activation. , 2018, Investigative ophthalmology & visual science.

[8]  D. Yanagisawa,et al.  Volumetric changes in the aging rat brain and its impact on cognitive and locomotor functions , 2017, Experimental Gerontology.

[9]  J. Choi,et al.  7,8-Dihydroxyflavone attenuates TNF-α-induced skin aging in Hs68 human dermal fibroblast cells via down-regulation of the MAPKs/Akt signaling pathways. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  Alison L. Reynolds,et al.  A Brain-Derived Neurotrophic Factor Mimetic Is Sufficient to Restore Cone Photoreceptor Visual Function in an Inherited Blindness Model , 2017, Scientific Reports.

[11]  M. Hickey,et al.  Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration , 2017, Scientific Reports.

[12]  M. Palmer,et al.  Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists , 2017, Science Signaling.

[13]  P. Bosco,et al.  Brain atrophy in Alzheimer’s Disease and aging , 2016, Ageing Research Reviews.

[14]  Mark A. Christopher,et al.  Automated Axon Counting in Rodent Optic Nerve Sections with AxonJ , 2016, Scientific Reports.

[15]  L. Tychsen,et al.  Neuroimaging evidence of deficient axon myelination in Wolfram syndrome , 2016, Scientific Reports.

[16]  K. Ye,et al.  Activation of muscular TrkB by its small molecular agonist 7,8-dihydroxyflavone sex-dependently regulates energy metabolism in diet-induced obese mice. , 2015, Chemistry & biology.

[17]  Se Jin Park,et al.  Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice , 2015, Scientific Reports.

[18]  M. Borowiec,et al.  Central Nervous System PET-CT Imaging Reveals Regional Impairments in Pediatric Patients with Wolfram Syndrome , 2014, PloS one.

[19]  Jun Chen,et al.  Effects of normal aging on myelin sheath ultrastructures in the somatic sensorimotor system of rats. , 2014, Molecular medicine reports.

[20]  Nick C Fox,et al.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.

[21]  S. Yu,et al.  7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease , 2014, Neuropsychopharmacology.

[22]  Paul H. E. Tiesinga,et al.  The Scalable Brain Atlas: Instant Web-Based Access to Public Brain Atlases and Related Content , 2013, Neuroinformatics.

[23]  T. Albini,et al.  Optic nerve histopathology in a case of Wolfram Syndrome: a mitochondrial pattern of axonal loss. , 2013, Mitochondrion.

[24]  F. Paul,et al.  Enlargement of Cerebral Ventricles as an Early Indicator of Encephalomyelitis , 2013, PloS one.

[25]  Alan R Harvey,et al.  Myelin sheath decompaction, axon swelling, and functional loss during chronic secondary degeneration in rat optic nerve. , 2012, Investigative ophthalmology & visual science.

[26]  Yan Zeng,et al.  7,8‐dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats , 2012, Journal of neurochemistry.

[27]  Shing-Hwa Liu,et al.  C/EBP Homologous Protein (CHOP) Deficiency Aggravates Hippocampal Cell Apoptosis and Impairs Memory Performance , 2012, PloS one.

[28]  M. Permutt,et al.  Early Brain Vulnerability in Wolfram Syndrome , 2012, PloS one.

[29]  A. Cardona,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[30]  N. Miller,et al.  Optic Nerve Histopathology in a Case of Wolfram Syndrome Demonstrates a Mitochondrial Pattern of Axonal Loss , 2012 .

[31]  Amity E. Green,et al.  Hippocampal Atrophy and Ventricular Enlargement in Normal Aging, Mild Cognitive Impairment (MCI), and Alzheimer Disease , 2012, Alzheimer disease and associated disorders.

[32]  S. A. E. Mkadem,et al.  Neurologic features and genotype‐phenotype correlation in Wolfram syndrome , 2011, Annals of neurology.

[33]  Yang Liu,et al.  A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone , 2010, Proceedings of the National Academy of Sciences.

[34]  Xiao-ming Shen,et al.  Forepaw Sensorimotor Deprivation in Early Life Leads to the Impairments on Spatial Memory and Synaptic Plasticity in Rats , 2010, Journal of biomedicine & biotechnology.

[35]  M. Weiner,et al.  Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls , 2009, NeuroImage.

[36]  Joe C. Adams,et al.  Wolfram syndrome: a clinicopathologic correlation , 2009, Acta Neuropathologica.

[37]  R. Bartha,et al.  Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. , 2008, Brain : a journal of neurology.

[38]  Yaniv Ziv,et al.  Toll-like receptors modulate adult hippocampal neurogenesis , 2007, Nature Cell Biology.

[39]  Sharon E. Lee,et al.  Ventricular volume and dementia progression in the Cardiovascular Health Study , 2007, Neurobiology of Aging.

[40]  Sharon E. Lee,et al.  Cerebral Ventricular Changes Associated With Transitions Between Normal Cognitive Function, Mild Cognitive Impairment, and Dementia , 2007, Alzheimer disease and associated disorders.

[41]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[42]  R M Douglas,et al.  Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system , 2005, Visual Neuroscience.

[43]  R. Douglas,et al.  Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. , 2004, Investigative ophthalmology & visual science.

[44]  Paul M. Thompson,et al.  Mapping hippocampal and ventricular change in Alzheimer disease , 2004, NeuroImage.

[45]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[46]  H. Adams,et al.  Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI , 2000, Neurology.

[47]  B. Hyman,et al.  Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer’s disease , 2000, Journal of Neuroimmunology.

[48]  M N Rossor,et al.  Progressive cerebral atrophy in MS , 2000, Neurology.

[49]  P. Behn,et al.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) , 1998, Nature Genetics.

[50]  T. Barrett,et al.  Wolfram (DIDMOAD) syndrome. , 1997, Journal of medical genetics.

[51]  G. L. Curran,et al.  Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. , 1996, Brain research. Molecular brain research.

[52]  M. Swift,et al.  Psychiatric findings in Wolfram syndrome homozygotes , 1990, The Lancet.

[53]  Xiaochuan Wang,et al.  7,8-Dihydroxyflavone ameliorates high-glucose induced diabetic apoptosis in human retinal pigment epithelial cells by activating TrkB. , 2018, Biochemical and biophysical research communications.

[54]  J. Sohng,et al.  7,8-Dihydroxyflavone inhibits adipocyte differentiation via antioxidant activity and induces apoptosis in 3T3-L1 preadipocyte cells. , 2016, Life sciences.

[55]  S. Graham,et al.  Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress , 2012, Journal of Molecular Neuroscience.